Ayyala R S
Glaucoma Service, Department of Ophthalmology, Tulane University Medical Center, New Orleans, LA, USA.
Surv Ophthalmol. 2000 Sep-Oct;45(2):91-105. doi: 10.1016/s0039-6257(00)00141-7.
Glaucoma remains the leading cause of blindness after penetrating keratoplasty. Post-keratoplasty glaucoma was originally described in 1969, and its management is still controversial. Recent developments in management include newer classes of drugs, surgical procedures, such as trabeculectomy with mitomycin-C, implantation of glaucoma drainage devices, and cyclodestructive procedures with Nd: YAG and diode lasers. However, the risk of graft failure continues to be high with all surgical procedures.
青光眼仍然是穿透性角膜移植术后失明的主要原因。角膜移植术后青光眼最初于1969年被描述，其治疗方法仍存在争议。近年来治疗方法的进展包括新型药物、手术操作，如丝裂霉素C小梁切除术、青光眼引流装置植入术以及钕:钇铝石榴石激光和二极管激光睫状体破坏术。然而，所有手术操作都存在较高的移植失败风险。
